JAK2-V617F activating mutation in acute myeloid leukemia: Prognostic impact and association with other molecular markers [15]

1. Vicente, C.
2. Vázquez, I.
3. Marcotegui, N.
4. Conchillo, A.
5. Carranza, C.
6. Rivell, G.
7. Bandrés, E.
8. Cristobal, I.
9. Lahortiga, I.
10. Calasanz, M.J.
11. Odero, M.D.